会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Aryloxy piperidinyl derivatives for the treatment of depression
    • 芳氧基哌啶衍生物用于治疗抑郁症
    • US06610712B2
    • 2003-08-26
    • US10000642
    • 2001-11-15
    • Richard E. MewshawDahui ZhouPing Zhou
    • Richard E. MewshawDahui ZhouPing Zhou
    • C07D40104
    • C07D401/06C07D405/14
    • This invention provides compounds useful in treating serotonin-related central nervous system disorders, including anxiety, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, sleep disorders, sexual dysfunction, alcohol and drug addiction, Alzheimer's disease, Parkinson's disease, obesity and migraine, the compounds having the general formula: wherein: R1 and R2 may each be H or an alkyl or alkoxy group; or R1 and R2 may be concatenated to form a bicyclic ring system with the phenyl ring to which they are bound; X is selected from hydrogen, halogen, cyano, C1-C6 alkoxy; Z is (CH2)n or carbonyl; n is 0, 1 or 2; the dashed line indicates an optional double bond; or a pharmaceutically acceptable salt thereof.
    • 本发明提供了可用于治疗血清素相关的中枢神经系统疾病的化合物,包括焦虑,广泛性焦虑症,恐慌症,强迫症,睡眠障碍,性功能障碍,酒精和药物成瘾,阿尔茨海默病,帕金森病,肥胖症和偏头痛 具有以下通式的化合物:其中:R 1和R 2可以各自为H或烷基或烷氧基; 或者R 1和R 2可以连接形成与它们所结合的苯环的双环系统; X选自氢,卤素,氰基,C 1 -C 6烷氧基; Z是(CH 2)n或羰基; n为0,1或2; 虚线表示可选的双键; 或其药学上可接受的盐。
    • 8. 发明授权
    • [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
    • [(吲哚-3-基) - 环烷基] -3-取代的氮杂环丁烷,用于治疗中枢神经系统疾病
    • US06245799B1
    • 2001-06-12
    • US09707146
    • 2000-11-06
    • Magda AsselinJohn W. EllingboeRichard E. Mewshaw
    • Magda AsselinJohn W. EllingboeRichard E. Mewshaw
    • A61K31404
    • C07D403/08
    • This invention provides novel compounds and pharmaceutical compositions and methods of using the compounds in the treatment of central nervous system disorders, such as anxiety and depression, the compounds having the formula I: wherein: X is N—R, O, S(O)m; m is 0 to 2; n is 0 to 4; Ar is an aryl group of 6 to 12 carbon atoms optionally substituted with 1 to 3 R3 groups, or a heteroaryl group of 4 to 10 carbon atoms optionally substituted with 1 to 3 R3 groups; R and R2 are independently H, straight chain alkyl of 1 to 6 carbon atoms, branched alkyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, alkoxycarbonyl of 1 to 6 carbon atoms, alkylcarbonyl of 1 to 6 carbon atoms, aminocarbonyl, or alkylaminocarbonyl of 1 to 4 carbon atoms; R1 and R3 are independently H, straight chain alkyl of 1 to 4 carbon atoms, branched alkyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, halo, alkoxy group of 1 to 4 carbon atoms, haloalkyl of 1 to 4 carbon atoms, OH, nitro, amino, sulfonyl, CN, carboxy, alkoxycarbonyl of 1 to 4 carbon atoms, alkylcarbonyl of 1 to 4 carbon atoms, aminocarbonyl, or alkylaminocarbonyl of 1 to 4 carbon atoms; or a pharmaceutically acceptable salt thereof.
    • 本发明提供了新的化合物和药物组合物和使用该化合物治疗中枢神经系统疾病如焦虑和抑郁的方法,具有式I的化合物:其中:X是N-R,O,S(O)m; m为0〜2; n为0〜4; Ar是任选被1至3个R 3基团取代的6至12个碳原子的芳基或任选被1至3个R 3基团取代的4至10个碳原子的杂芳基; R 2和R 2独立地是H,直链烷基 1至6个碳原子,3至6个碳原子的支链烷基,3至6个碳原子的环烷基,1至6个碳原子的烷氧基羰基,1至6个碳原子的烷基羰基,氨基羰基或1至4个碳原子的烷基氨基羰基; R 1和R 3独立地为H,1至4个碳原子的直链烷基,3至6个碳原子的支链烷基,3至8个碳原子的环烷基,卤素,1至4个碳原子的烷氧基,1至4个卤代烷基 碳原子,OH,硝基,氨基,磺酰基,CN,羧基,1至4个碳原子的烷氧基羰基,1至4个碳原子的烷基羰基,氨基羰基或1至4个碳原子的烷基氨基羰基;或其药学上可接受的盐。